Cite
Expression Profiling of Blood-based Inflammatory (pro/anti) Biomarkers Including HSP27, CD14 and CRP in Insulin Resistance Type-2 Diabetic Patients with CVD Complication
MLA
M. Zafar, et al. “Expression Profiling of Blood-Based Inflammatory (pro/Anti) Biomarkers Including HSP27, CD14 and CRP in Insulin Resistance Type-2 Diabetic Patients with CVD Complication.” Metabolism, vol. 142, May 2023, p. 155426. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2e204745f8e817ef89a08db3990a774c&authtype=sso&custid=ns315887.
APA
M. Zafar, M.R. Mirza, I.R. Malik, F.R. Awan, M.H. Ovais, & Z. Ali. (2023). Expression Profiling of Blood-based Inflammatory (pro/anti) Biomarkers Including HSP27, CD14 and CRP in Insulin Resistance Type-2 Diabetic Patients with CVD Complication. Metabolism, 142, 155426.
Chicago
M. Zafar, M.R. Mirza, I.R. Malik, F.R. Awan, M.H. Ovais, and Z. Ali. 2023. “Expression Profiling of Blood-Based Inflammatory (pro/Anti) Biomarkers Including HSP27, CD14 and CRP in Insulin Resistance Type-2 Diabetic Patients with CVD Complication.” Metabolism 142 (May): 155426. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2e204745f8e817ef89a08db3990a774c&authtype=sso&custid=ns315887.